Agenda Details

Rapidly evolving advances in gene and cell therapy have led to scientific democratization of therapeutic possibilities to treat genetic disorders, even for N=1 indications. This session will overview selected aspects of developing treatments for ultra rare disorders, including clinical examples, regulatory considerations, and models to support the development of gene therapy for orphan indications. The presentation will be followed by a panel discussion led by clinical and regulatory experts, with audience engagement encouraged.